Francesc Bosch - Dissemin

Language
Login

All papers authored by Francesc Bosch

This paper is made freely available by the publisher.

2024 Lihua E. Budde

ORCID

, Sarit Assouline

ORCID

, Laurie H. Sehn

ORCID

, Stephen J. Schuster, Sung-Soo Yoon

ORCID

, Dok Hyun Yoon

ORCID

, Matthew J. Matasar

ORCID

, Francesc Bosch

ORCID

ORCID

, Loretta J. Nastoupil

ORCID

ORCID

, Mazyar Shadman

ORCID

, Catherine Diefenbach

ORCID

, Chan Yoon Cheah

ORCID

, Connie Y. Ma and 5 other authors

Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study

Download from doi.org

This paper is made freely available by the publisher.

2022 Pau Abrisqueta, Daniel Medina

ORCID

, Guillermo Villacampa

ORCID

ORCID

, Miguel Alcoceba, Julia Carabia, Joan Boix, Barbara Tazón-Vega, Gloria Iacoboni

ORCID

, Sabela Bobillo, Ana Marín-Niebla

ORCID

, Marcos González

ORCID

, Thorsten Zenz, Marta Crespo

ORCID

, Francesc Bosch

ORCID

A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression

Download from doi.org

This paper is made freely available by the publisher.

Lihua E. Budde

ORCID

, Budde Le, Sarit Assouline

ORCID

, Laurie H. Sehn

ORCID

, Sung-Soo Yoon, Stephen J. Schuster, Dok Hyun Yoon

ORCID

, Sehn Lh, Schuster Sj, Matthew J. Matasar

ORCID

, Yoon Ss, Yoon Dh, Francesc Bosch

ORCID

ORCID

, Loretta J. Nastoupil and 16 other authors

Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2021 Marcelo Lima Ribeiro, Diana Reyes-Garau, Meritxell Vinyoles

ORCID

, Núria Profitós Pelejà

ORCID

, Juliana Carvalho Santos

ORCID

, Marc Armengol

ORCID

, Miranda Fernández-Serrano

ORCID

, Alícia Sedó Mor, Joan J. Bech-Serra, Pedro Blecua

ORCID

ORCID

, Carolina De La Torre

ORCID

, Hari Miskin, Manel Esteller

ORCID

, Francesc Bosch

ORCID

and 3 other authors

Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non–Hodgkin Lymphoma

Upload

This paper is made freely available by the publisher.

Isabel Jiménez, Bárbara Tazón-Vega, Pau Abrisqueta, Juan C. Nieto, Sabela Bobillo, Carles Palacio-García, Júlia Carabia, Rafael Valdés-Mas

ORCID

, Magdalena Munuera, Lluís Puigdefàbregas, Genís Parra, Anna Esteve-Codina, Clara Franco-Jarava, Gloria Iacoboni, María José Terol and 3 other authors

Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia

Download from doi.org

Distributing this paper is prohibited by the publisher

Cecilia Carpio

ORCID

, Gloria Iacoboni, Guillermo Villacampa

ORCID

, Eva Catalá, Sabela Bobillo, Ana Pérez, Moraima Jiménez, Laura Segura, Mireia Olivé, Anna Farriols, Pau Abrisqueta, David Valcárcel

ORCID

, María Josep Carreras, Francesc Bosch

ORCID

ORCID

Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center

Upload

This paper is made freely available by the publisher.

Francesc Bosch

ORCID

, Blanca Navarro, Marta Crespo

ORCID

, Miguel Alcoceba

ORCID

, Julio Bravo Sánchez, Barbara Tazón, Alicia Serrano, María García Álvarez

ORCID

, Lydia González Serrano, Pablo Alonso-Torres, Miguel Villanueva, Cristina Loriente, Pau Abrisqueta, Manel Peiró, José Antonio García-Marco

ORCID

and 2 other authors

Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative

Download from link.springer.com

This paper is made freely available by the publisher.

2020 Olga Salamero

ORCID

, Pau Montesinos

ORCID

, Christophe Willekens

ORCID

, José Antonio Pérez-Simón

ORCID

, Arnaud Pigneux, Christian Récher, Rakesh Popat

ORCID

, Cecilia Carpio, César Molinero

ORCID

, Cristina Mascaró, Joaquim Vila, M. Isabel Arévalo

ORCID

ORCID

, Carlos Buesa, Francesc Bosch

ORCID

and 1 other authors

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

Download from doi.org

Distributing this paper is prohibited by the publisher

María Laura Fox

ORCID

, Irene García-Cadenas

ORCID

, Ariadna Martínez Pérez, Guillermo Villacampa

ORCID

, José Luis Piñana

ORCID

, Guillermo Ortí

ORCID

ORCID

, Elisa Roldán

ORCID

, Anna Bosch Vilaseca, Rodrigo Martino

ORCID

, Olga Salamero

ORCID

, Silvana Saavedra, Juan Carlos Hernandez-Boluda

ORCID

, Albert Esquirol

ORCID

ORCID

and 5 other authors

Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis

Upload

This paper is made freely available by the publisher.

Juan C. Nieto

ORCID

, Elisa Roldán, Isabel Jiménez

ORCID

ORCID

, Júlia Carabia, Guillermo Ortí

ORCID

, Lluís Puigdefàbregas, Laura Gallur, Gloria Iacoboni, Priyanka Raheja, Ana Pérez, Sabela Bobillo, Olga Salamero, Carlos Palacio, David Valcárcel and 3 other authors

Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy

Download from www.nature.com

This paper is made freely available by the publisher.

Leo I. Gordon

ORCID

, Jason B. Kaplan, Rakesh Popat, Howard A. Burris, Silvia Ferrari

ORCID

, Sumit Madan, Manish R. Patel, Giuseppe Gritti

ORCID

, Dima El-Sharkawi

ORCID

, Ian Chau

ORCID

, John A. Radford, Jaime Perez de Oteyza, Pier Luigi Zinzani, Jaime Pérez de Oteyza

ORCID

, Pier Luigi Zinzani and 11 other authors

Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-cell Lymphoma

Download from aacrjournals.org

This paper was not found in any repository, but could be made available legally by the author.

2019 Francesc Bosch

ORCID

, Guy Cantin, Agostino Cortelezzi, Wolfgang Knauf, Mourad Tiab, Mehmet Turgut, Andrey Zaritskey, Jean-Louis Merot, Eugen Tausch, Kerstin Trunzer, Susan Robson, Ekaterina Gresko, Sebastian Böttcher, Robin Foà, Stephan Stilgenbauer and 1 other authors

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

Upload

This paper was not found in any repository, but could be made available legally by the author.

Francesc Bosch

ORCID

, Riccardo Dalla-Favera

Chronic lymphocytic leukaemia: from genetics to treatment

Upload

This paper was not found in any repository, but could be made available legally by the author.

2017 Guillermo Orti

ORCID

, Pere Barba, Laura Fox

ORCID

, Olga Salamero

ORCID

, Francesc Bosch

ORCID

, David Valcarcel

Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

J. A. García-Marco, J. Delgado, J. A. Hernández-Rivas, Á. Ramírez Payer, J. Loscertales Pueyo, I. Jarque, P. Abrisqueta, P. Giraldo, R. Martínez, L. Yáñez, M. J. Terol, M. González, F. Bosch

ORCID

Update of the Grupo Español de Leucemia Linfocítica Crónica clinical guidelines of the management of chronic lymphocytic leukemia | Actualización de las guías nacionales de consenso del Grupo Español de Leucemia Linfocítica Crónica para el tratamiento y seguimiento de la leucemia linfocítica crónica

Upload

This paper is made freely available by the publisher.

2016 Noelia Purroy, Júlia Carabia, Pau Abrisqueta, Leire Egia

ORCID

, Meritxell Aguiló, Cecilia Carpio, Carles Palacio, Marta Crespo

ORCID

, Francesc Bosch

ORCID

Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells

Download from doi.org

This paper is available in a repository.

N. StÃ¤dler, Nicolas Städler

ORCID

, Aijing Shang, Francesc Bosch

ORCID

, Andrew Briggs, Valentin Goede, Aurelien Berthier, Corinne Renaudin, Veronique Leblond

A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic Leukemia

Download from link.springer.com

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

R. M. de Tute, A. C. Rawstron, C. Fazi, A. Agathangelidis, Rawstron Ac, N. Villamor, R. Letestu, J. Nomdedeu

ORCID

, C. Palacio, K.-A. Kreuzer, O. Stehlikova, S. Liptrot, D. O'Brien, C. Yuan, A. P. Kater and 40 other authors

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.

Upload

This paper is made freely available by the publisher.

Gonzalo Blanco, Anna Puiggros, Panagiotis Baliakas, Anastasia Athanasiadou, MaDolores Garcia-Malo, Rosa Collado

ORCID

, Aliki Xochelli, Maria Rodriguez-Rivera, Margarita Ortega, Mª Jose Calasanz

ORCID

, Elisa Luno, MaTeresa T. Vargas, Javier Grau, Carolina Martinez-Laperche, Alberto Valiente and 17 other authors

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

Download from doi.org

This paper is made freely available by the publisher.

2015 José Ángel Hernández, Jose Angel Hernandez, Maria Hernandez-Sanchez, J. A. Hernández, Ana Eugenia Rodriguez-Vicente, María Hernández-Sánchez, Ana Eugenia Rodríguez-Vicente, Vera Grossmann, Rosa Collado

ORCID

, Cecilia Heras, Anna Puiggros, Ana Africa Martin, Ignacio de la Fuente, A. A. Martín, Noemí Puig and 25 other authors

A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia

Download from dx.doi.org

Missing publications? Search for publications with a matching author name.